MCCANN JOE A. 4
4 · POINT Biopharma Global Inc. · Filed Mar 30, 2023
Insider Transaction Report
Form 4
MCCANN JOE A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-28+692,643→ 692,643 totalExercise: $6.78Exp: 2029-03-28→ Common Stock (692,643 underlying)
Footnotes (1)
- [F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.